This company has been acquired
Walgreens Boots Alliance Management
Management criteria checks 3/4
Walgreens Boots Alliance's CEO is Tim Wentworth, appointed in Oct 2023, has a tenure of 1.83 years. total yearly compensation is $13.50M, comprised of 9.6% salary and 90.4% bonuses, including company stock and options. directly owns 0.015% of the company’s shares, worth $1.59M. The average tenure of the management team and the board of directors is 2.1 years and 3.9 years respectively.
Key information
Tim Wentworth
Chief executive officer
US$13.5m
Total compensation
| CEO salary percentage | 9.56% |
| CEO tenure | 1.8yrs |
| CEO ownership | 0.02% |
| Management average tenure | 2.1yrs |
| Board average tenure | 3.9yrs |
Recent management updates
Recent updates
Walgreens Boots Alliance: Merger Arbitrage Opportunity
Jul 29Walgreens: Acquisition Is The Best-Case Scenario For The Company
Apr 15What To Do After Sycamore Partners Agrees To Buy Walgreens
Mar 07Walgreens Boots Alliance (NASDAQ:WBA) Has No Shortage Of Debt
Feb 13
Walgreens Boots Alliance: Larger Structural Problems Remain
Feb 11Walgreens: Don't Expect The Dividend To Come Back Anytime Soon
Feb 03Walgreens Could Have Reached Its Bottom, But Caution Is Still Advised
Jan 08Walgreens' Rally Sputters Amid Takeover Chatter (Rating Downgrade)
Dec 20How Investors Should Assess The Potential Walgreens Buyout
Dec 11Walgreens: 11.9% Dividend Yield Still On Unsteady Legs
Nov 18Walgreens Q4: 2 Signs Of A Dividend Trap
Oct 29Walgreens: Undervalued Pharma Giant Poised For A Turnaround Amid Cost-Cutting And Activist Investor Potential
Oct 23Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?
Oct 17Walgreens: A Turnaround Stock To Avoid
Oct 15Walgreens Stock: Cheap At 3x FWD P/E, But Still Not Worth Buying
Sep 29Walgreens: Short Interest Surge Indicates It's Time To Cut Your Losses
Sep 06Is Walgreens Ready To Rebound?
Aug 23Walgreens Boots Alliance: Likely A Value Trap, But Could Be A Speculative Long-Term Play
Aug 13Walgreens: A Painful Turnaround Lesson
Aug 02Walgreens: Here's What Comes Next
Jul 09Walgreens: Yielding Over 8% Following The Earnings Drop
Jul 02Walgreens: Beware The Value Trap Ahead Of Earnings
Jun 24Walgreens: Another Dividend Cut Could Be Coming Soon (Rating Downgrade)
May 305 Reasons Walgreens Fell By 6.4% To Nearly 25-Year Lows
May 22CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| May 31 2025 | n/a | n/a | -US$6b |
| Feb 28 2025 | n/a | n/a | -US$6b |
| Nov 30 2024 | n/a | n/a | -US$9b |
| Aug 31 2024 | US$13m | US$1m | -US$9b |
Compensation vs Market: Tim's total compensation ($USD13.50M) is about average for companies of similar size in the US market ($USD13.55M).
Compensation vs Earnings: Insufficient data to compare Tim's compensation with company performance.
CEO
Tim Wentworth (65 yo)
Mr. Timothy C. Wentworth, also known as Tim, served as Director of Ushur, Inc. since February 2022. He served as the Chief Executive Officer of Evernorth at Evernorth Health, Inc. (formerly known as Expres...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 13.3yrs | US$7.87m | 16.82% $ 1.7b | |
| CEO & Director | 1.8yrs | US$13.50m | 0.015% $ 1.6m | |
| Executive VP & Global CFO | 2.1yrs | US$5.54m | 0.0071% $ 733.6k | |
| Chief Operating Officer of International | no data | US$6.82m | 0.25% $ 25.8m | |
| Executive VP & President of Walgreens Health | no data | US$6.65m | 0.0077% $ 792.4k | |
| Senior VP | 2.1yrs | no data | 0.0027% $ 273.4k | |
| Senior VP and Global Chief Compliance & Ethics Officer | no data | no data | no data | |
| Executive VP & Global Chief Legal Officer | 1.3yrs | no data | 0.0050% $ 511.7k | |
| Executive VP & Chief Human Resources Officer | 1.4yrs | no data | 0.0058% $ 594.3k | |
| Head of M&A - Asia | no data | no data | no data | |
| Executive VP | 3.8yrs | no data | 0.0091% $ 935.8k | |
| Senior VP & Chief Pharmacy Officer of Walgreen Co. | 2.4yrs | no data | 0.0045% $ 465.3k |
Experienced Management: WBA's management team is considered experienced (2.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 13.3yrs | US$7.87m | 16.82% $ 1.7b | |
| CEO & Director | 1.8yrs | US$13.50m | 0.015% $ 1.6m | |
| Lead Independent Director | 15.3yrs | US$3.50m | 0.00025% $ 25.8k | |
| Independent Director | 4.8yrs | US$300.00k | 0.00051% $ 52.6k | |
| Independent Director | 18.8yrs | US$469.99k | 0.0044% $ 452.9k | |
| Independent Director | 10.3yrs | US$320.00k | 0.0058% $ 596.4k | |
| Independent Director | 2.8yrs | US$299.99k | 0.0055% $ 568.5k | |
| Independent Director | 13.3yrs | US$432.50k | 0.00014% $ 14.4k | |
| Independent Director | less than a year | no data | 0.00041% $ 42.3k | |
| Independent Director | 2.9yrs | US$300.00k | 0.00035% $ 36.1k | |
| Independent Director | 2.1yrs | US$149.99k | 0.0033% $ 337.4k | |
| Independent Director | 1.6yrs | US$59.89k | no data |
Experienced Board: WBA's board of directors are considered experienced (3.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/08/27 02:02 |
| End of Day Share Price | 2025/08/27 00:00 |
| Earnings | 2025/05/31 |
| Annual Earnings | 2024/08/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Walgreens Boots Alliance, Inc. is covered by 35 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Christopher Graja | Argus Research Company |
| Samuel Hudson | Atlantic Equities LLP |
| Eric Coldwell | Baird |